The regulatory mechanisms involved in the control of the nuclear NADPH-dependent 3-ketosteroid 5a-reductase (5a-reductase) activity were studied in liver, kidney and prostate. The substrate used was [1,2-3H]androst-4-ene-3,17-dione (androstenedione) (for liver and kidney) or [4-14C]androstenedione (for prostate). The hepatic nuclear 5ca-reductase activity was greater in female than in male rats, was greater in adult than in prepubertal female rats, increased after castration of male rats, but was not affected by treatment with testosterone propionate or oestradiol benzoate. These regulatory characteristics are in part different from those previously described for the hepatic microsomal 5a-reductase. The renal nuclear metabolism of androstenedione, i.e. 5ca reduction and 17,6-hydroxy steroid reduction, was relatively unaffected by sex, age, castration and treatment with testosterone propionate. However, treatment of castrated male rats with oestradiol benzoate led to a significant increase in the 5a-reductase activity and a significant decrease in the 17f,-hydroxy steroid reductase activity. Finally, the nuclear 5ac-reductase activity in prostate was androgen-dependent, decreasing after castration and increasing after treatment with testosterone propionate. In conclusion, the nuclear 5ca-reductase activities in liver, kidney and prostate seem to be under the control of distinctly different regulatory mechanisms. The hypothesis is presented that whereas the prostatic nuclear 5a-reductase participates in the formation of a physiologically active androgen, 5ca-dihydrotestosterone, this may not be the true function of the nuclear 5ca-reductase in liver and kidney. These enzymes might rather serve to protect the androgen target sites in the chromatin from active androgens (e.g. testosterone) by transforming them into less active androgens (e.g. 5ca-androstane-3,17-dione and/or 5a-dihydrotestosterone).
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The intranuclear formation of the physiologically active androgen 17,8-hydroxy-5a-androstan-3-one (5ac-dihydrotestosterone) from testosterone, first shown in the prostate (Anderson & Liao, 1968; Bruchovsky & Wilson, 1968) , was originally considered to be a typical feature of the accessory sex organs in the male rat (Bruchovsky & Wilson, 1968) . Recent studies, however, have shown the presence of nuclear NADPH-dependent 3-oxo steroid 5a-reductases (5aS-reductases) in tissues other than those classically regarded as androgen target organs. Verhoeven & De Moor (1971 ) described a nuclear 5a-reductase in rat kidney and we characterized a 5ca-reductase enzyme in nuclei from rat liver (Gustafsson & Pousette, 1974) . The general properties and substrate specificity of the hepatic nuclear 5a-reductase resembled those described for the nuclear 5aS-reductases in prostate and kidney and seemed to be different from hepatic microsomal 5a-reductase. Nuclear 5a-reductase activity is higher in female than in male rat liver, which suggests a different type of regulation mechanism for the Vol. 142 hepatic enzyme than for the prostatic enzyme, the activity of which has been found to be androgendependent (Shimazaki et al., 1969 (Shimazaki et al., , 1972 Moore & Wilson, 1973 
Animal experiments
Rats of the Sprague-Dawley strain were used. In one series of experiments male and female rats were castrated at the age of 56 days. At 1 day after the operation daily injections of 0.5ml of propylene glycol (control group), 400pug of testosterone propionate in 0.5ml of propylene glycol or 100,ug of oestradiol benzoate in 0.5ml of propylene glycol were commenced on the male rats and were continued for 7 days. After this period the animals were killed and studied with respect to the nuclear metabolism of androstenedione in liver and kidney. The castrated female rats that received no treatment were also killed 7 days after the operation and the nuclear enzyme activities in liver and kidney investigated. In a separate experiment these parameters were studied in male and female rats of 28 and 56 days of age. The hepatic nuclear 5a-reductase activity was also studied in male rats that had been castrated on theirfirst day oflife (Einarssonetal., 1973; Gustafsson & Stenberg, 1974a) . Finally, the nuclear Sa-reductase activity in prostate was investigated in intact 56.day-old rats and in rats castrated at 56 days of age and treated for 4 consecutive days with propylene glycol (control rats), testosterone propionate or oestradiol benzoate at the doses described above.
Preparation ofnuclei
The method for preparation of nuclei from liver, kidney and prostate was a modification of that described for liver nuclei by Gustafsson & Pousette (1974) . The animals were killed by cervical dislocation, the liver was perfused with cold 0.9% NaCl and the liver, one kidney and the ventral prostate were quickly removed, rinsed in cold 0.9% NaCl and cut into small pieces in lOml of medium A (0.88M-sucrose-1.5mM-CaC12-1mM-MgSO4-O.01 M-Tris-HCl buffer, pH7.4) (Verhoeven & De Moor, 1972) and homogenized. Homogenate corresponding to 1 g of liver tissue and homogenates of kidney (1.Og) and prostate (0.5g) were centrifuged at 20000g for 30min. The sediments were resuspended in 2.2M-sucrose and centrifuged at 58000g for 90min in a SW50.1 rotor. The pellets obtained were resuspended and homogenized in 2.5ml of medium A and layered over 2.5ml of 2.2M-sucrose and centrifuged again at 58000g for 30min in an SW 50.1 rotor. The sediment was suspended in 2ml of medium B (5OmM-NaCl-5mM-MgSO4-50um-EDTA-O.O1M-Tris-HCl buffer, pH7.4) and homogenized. A sample of the nuclear preparation was always taken for control of purity and for calculation of concentration ofnuclei by using phasecontrast microscopy and a Burker counting chamber. In a previous study a similar purification method was shown to give a pure hepatic nuclear preparation as judged by electron microscopy (Gustafsson & Pousette, 1974) . A sample of the nuclear preparation was also taken for determination of DNA (Burton, 1956 ) with calf thymus DNA (Sigma Chemical Co.) as standard.
Conditions of incubation
Incubations with nuclear preparations were always started 6h after the rats were killed and never later than 30min after the nuclear preparation was ready. The incubation conditions were tested and were designed to give conversions linear with respect to time and enzyme concentrations.
In all incubations a total incubation volume of 1 ml of medium B was used; this incubation mixture also contained 1 xlO6d.p. androstenedione (for prostate nuclei) (giving a substrate concentration of0.76gM), and an NADPHregenerating system consisting of NADP+ (0.4mM), DL-isocitric acid (3.87mM), isocitrate dehydrogenase (0.4unit/ml) and MnCI2 (9.2guM).
In the incubations with liver nuclei the amount of nuclei added and the length of the incubation time were varied according to the type of metabolism characterizing the nuclear preparation in question. For a female type of metabolism (high 5a-reductase activity) about 2 x 106 nuclei (corresponding to about 21.4,ug of DNA)/ml were added and an incubation time of 10min was used. For a male type of metabolism (low 50-reductase activity) a concen-1974 274' tration of about 6 x 106 nuclei (corresponding to about 64.2,ug of DNA)/ml and an incubation time of 20min were used.
Incubations with kidney and prostate nuclei were carried out in the presence of dithiothreitol (0.06M). The concentration of dithiothreitol was chosen to give an optimum activity of 5a-reductase. The concentration of nuclei generally corresponded to about 200 and 65,ug of DNA for kidney and prostate nuclei respectively. Incubations with kidney nuclei were carried out for 20min, whereas those with prostate nuclei were for 60min.
The incubations were terminated by the addition of 5ml of chloroform-methanol (2:1, v/v). The mixture was shaken well and then left for 12-16h. The chloroform phase was transferred to another tube, evaporated to dryness under N2 and the dry extract was redissolved in about 500,1 ofmethanol.
Analysis of incubation extracts
The extracts from the incubations were analysed by t.l.c. in the solvent system chloroform-ethyl acetate (4:1, v/v). The t.l.c. plates were scanned for radioactivity with a Berthold Model II thin-layer scanner (Berthold, Wildbad, Germany). This technique allowed a reliable quantification of formed metabolites and residual substrate. In selected cases the radioactive zones were scraped off the t.l.c. plates, eluted with methanol and subjected to radiog.l.c.-mass spectrometry (Gustafsson & Pousette, 1974) . A compound was considered identified if it had the same mass spectrum and g.l.c behaviour as the reference compound. Retention times (tR: s) were calculated relative to that of 5a-cholestane (tR = 1.00).
For the statistical analysis Student's t test was used and the significance level was set at 0.05.
Results
Regulation of hepatic nuclear 5a-reductase activity As described by Gustafsson & Pousette (1974) , only 5a-androstane-3,17-dione is formed from androstenedione after incubation with liver nuclei from female rats under the standard conditions given above. When incubations were performed with liver nuclei from male rats 5a-androstane-3,17-dione still constituted a major metabolite, but 3,B-hydroxy5a-androstan-17-one and testosterone (small amounts) were also formed. The 5a-reductase activity in male liver nuclei was measured as the sum of the amounts of 5a-androstane-3,17-dione and 3,Bhydroxy-5a-androstan-17-one formed. Testosterone was only formed in normal adult male rats.
In agreement with our earlier observations (Gustafsson & Pousette, 1974) 5a-reductase activity than normal adult male rats (see Fig. 1 ). The enzyme activity in 28-day-old female rats was only about 12% of that in adult female rats, whereas the 5a-reductase activity in 28-day-old male rats was similar to that in adult male rats. Castration of male rats, either neonatally or postpubertally, resulted in an almost tenfold stimulation of the nuclear 5a-reductase activity. Castration of adult female rats did not result in any change in the activity of the Sa-reductase. No effects on the enzyme activity were seen after the treatment of castrated male rats with testosterone propionate or oestradiol benzoate.
Regulation of renal nuclear metabolism
Incubation ofrenal nuclear preparations from male and female rats with 4-androstene-3, 1 7-dione resulted in the formation of two metabolites. One was identified as S5a-androstane-3,17-dione (tR on SE-30, 0.45). The other metabolite was identified as testosterone (tR of the trimethylsilyl ether on SE-30, 0.66).
In contrast with the hepatic enzyme activity the renal nuclear 5a-reductase activity (measured as the amount of 5a-androstane-3,17-dione formed from androstenedione) was not characterized by any sexual differences, neither in adults nor in 28-day-old animals (see Fig. 2 ). The younger animals tended to have a slightly lower enzyme activity than the older animals, but no significant differences were observed. The enzyme activity was not influenced by castration.
When castrated male rats were treated with testosterone propionate, no significant change in the renal nuclear 5a-reductase activity was observed. (4) (4) (12) (8) (4) (4) (4) (4) Fig. 2. Activity of renal nuclear 5a-reductase active on androstenedione in male and female rats after castration and treatment with steroid hormones For further details see the legend to Fig. 1 . Significant effects obtained after hormone treatment when compared with control values (C) are indicated in the bars by * (P<0.05). or *** (P<0.001). However, oestradiol benzoate treatment of castrated male rats resulted in a more than fivefold stimulation (P < 0.05) of the enzyme activity. The renal nuclear 17/i-hydroxy steroid reductase activity (measured as the amount of testosterone formed from androstenedione) was also relatively uninfluenced by age, sex, castration and treatment with testosterone propionate (see Fig. 3 ). After treatment of castrated male rats with oestradiol benzoate, the enzyme activity was decreased by 40 % (P<0.05).
Regulation ofnuclear 5Sa-reductase activity in prostate When nuclear preparations from prostate were incubated with androstenedione only 5cc-androstane-3,17-dione was formed. Castration resulted in a decrease in the 5a-reductase activity by about 60% (P<0.05) (see Fig. 4 ). The enzyme activity was completely restored by treatment with testosterone propionate. Treatment of castrated male rats with oestradiol benzoate had no effect on the activity of the nuclear 5a-reductase.
Discussion
In the present study the prostatic nuclear 5a-reductase activity was found to be androgendependent. This agrees with the findings of Shimazaki et al. (1969 Shimazaki et al. ( , 1972 and Moore & Wilson (1973) , who showed that the 5a-reductase activity in rat ventral prostate decreased after castration and was increased after testosterone administration. In contrast with the prostatic enzyme activity, the hepatic nuclear 5a-reductase activity in male rats was markedly increased after castration. This finding was not unexpected in view of the much more efficient 5a reduction in liver nuclei from female rats than from male rats, and this reaction also conforms to the regulation pattern characterizing the rat liver microsomal 5a-reductase enzyme (Yates et al., 1958; Einarsson et al., 1973) . Similarly, the increase in nuclear 5a-reductase activity with age shown in female rats is paralleled by an age-dependent increase in microsomal 5a-reductase activity (Yates et al., 1958) . Quite unexpectedly, however, the higher activity of nuclear 5a-reductase in castrated male 1974 276 I. .I rats was not affected by androgen or oestrogen treatment, which contrasts with the suppression and stimulation respectively of microsomal 5a-reductase activity after similar treatment (Einarsson et al., 1973) . Likewise, neonatal castration of male rats did not completely alter the nuclear 5a-reductase activity to the pattern found in female rats, whereas this treatment leads to complete alteration to the female pattern of the microsomal 5a-reductase activity in male rats (Einarsson et al., 1973; Gustafsson & Stenberg, 1974a) .
A third type of regulation pattern was seen for the renal nuclear 5a-reductase activity. In this case the enzyme activity was practically unaffected by age, sex, castration and treatment with testosterone but markedly changed after treatment with oestradiol. A similar type of regulation also characterized the other renal enzyme studied, 17,B-hydroxy steroid reductase.
The present study gives further evidence that the hepatic microsomal and nuclear 5a-reductase enzyme activities represent two separate enzyme systems subjected to different regulatory mechanisms. As Gustafsson & Pousette (1974) pointed out, it is difficult to consider hepatic nuclear 5a-reductase as an enzyme activating androgens during their transport from cytoplasm to nuclei, since female rats, which respond much less well to androgen treatment than male rats with respect to androgenregulated hepatic enzymes (Berg & Gustafsson, 1973; Gustafsson & Stenberg, 1974b) , have a higher nuclear 5a-reductase activity than the male counterparts. It is possible that some other metabolite of testosterone than 5a-dihydrotestosterone is the physiologically active androgen in liver tissue and that the high nuclear 5a-reductase activity in female nuclei protects the nuclear androgen target sites from active androgens. Possibly the nuclear 5a-reductase in kidney might serve a similar function. Recent findings seem to indicate that testosterone rather than 5a-dihydrotestosterone is the physiologically active androgen in kidney tissue (Bardin et al., 1973) . The marked increase in renal nuclear 5a-reductase activity and significant decrease in 17fi-hydroxy steroid reductase activity after treatment with oestradiol benzoate may be interpreted as an antiandrogen-induced change in the nuclear androgen metabolism, from pathways leading to testosterone towards pathways leading to less active 5a-reduced 17-oxo steroids.
In conclusion, the present work indicates that the nuclear 5a-reductase activities in rat liver, kidney and prostate are subject to distinctly different regulatory control mechanisms. These results are difficult to reconcile with the hypothesis that androgen action in peripheral target organs generally is mediated by 5-dihydrotestosterone, formed by androgen-dependent nuclear and/or cytoplasmic 5-reductases. The general applicability of the findings on the mechanism of action of androgens in the prostate should be judged with caution until more information is available about regulation of androgen metabolism in other target organs.
